Annual Operating Expenses
$24.60 M
-$4.28 M-14.81%
December 31, 2024
Summary
- As of February 26, 2025, APVO annual total operating expenses is $24.60 million, with the most recent change of -$4.28 million (-14.81%) on December 31, 2024.
- During the last 3 years, APVO annual operating expenses has fallen by -$9.09 million (-26.98%).
- APVO annual operating expenses is now -69.58% below its all-time high of $80.87 million, reached on December 31, 2014.
Performance
APVO Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Expenses
$6.38 M
+$1.17 M+22.42%
December 31, 2024
Summary
- As of February 26, 2025, APVO quarterly total operating expenses is $6.38 million, with the most recent change of +$1.17 million (+22.42%) on December 31, 2024.
- Over the past year, APVO quarterly operating expenses has stayed the same.
- APVO quarterly operating expenses is now -70.38% below its all-time high of $21.55 million, reached on December 31, 2015.
Performance
APVO Quarterly Operating Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
APVO Operating Expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.8% | 0.0% |
| 3 y3 years | -27.0% | 0.0% |
| 5 y5 years | -39.9% | 0.0% |
APVO Operating Expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -27.0% | at low | -26.9% | +22.4% |
| 5 y | 5-year | -39.9% | at low | -31.4% | +22.4% |
| alltime | all time | -69.6% | at low | -70.4% | +22.4% |
Aptevo Therapeutics Operating Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $24.60 M(-14.8%) | $6.38 M(+22.4%) |
| Sep 2024 | - | $5.21 M(-13.5%) |
| Jun 2024 | - | $6.02 M(-13.7%) |
| Mar 2024 | - | $6.98 M(+9.4%) |
| Dec 2023 | $28.88 M(-9.1%) | $6.38 M(-2.7%) |
| Sep 2023 | - | $6.56 M(-19.8%) |
| Jun 2023 | - | $8.18 M(+5.4%) |
| Mar 2023 | - | $7.76 M(+0.9%) |
| Dec 2022 | $31.75 M(-5.7%) | $7.68 M(-1.3%) |
| Sep 2022 | - | $7.78 M(+2.9%) |
| Jun 2022 | - | $7.56 M(-13.3%) |
| Mar 2022 | - | $8.72 M(+13.2%) |
| Dec 2021 | $33.69 M(+5.9%) | $7.71 M(-1.8%) |
| Sep 2021 | - | $7.85 M(-11.2%) |
| Jun 2021 | - | $8.83 M(-5.1%) |
| Mar 2021 | - | $9.31 M(+1.3%) |
| Dec 2020 | $31.80 M(-22.4%) | $9.19 M(+19.2%) |
| Sep 2020 | - | $7.71 M(+5.9%) |
| Jun 2020 | - | $7.28 M(-4.5%) |
| Mar 2020 | - | $7.62 M(-4.0%) |
| Dec 2019 | $40.96 M | $7.94 M(-30.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2019 | - | $11.46 M(+10.1%) |
| Jun 2019 | - | $10.40 M(-6.8%) |
| Mar 2019 | - | $11.16 M(-27.9%) |
| Dec 2018 | $63.52 M(-0.1%) | $15.48 M(-0.2%) |
| Sep 2018 | - | $15.51 M(-7.3%) |
| Jun 2018 | - | $16.74 M(+6.0%) |
| Mar 2018 | - | $15.79 M(-11.0%) |
| Dec 2017 | $63.60 M(-2.6%) | $17.74 M(+21.1%) |
| Sep 2017 | - | $14.65 M(-3.7%) |
| Jun 2017 | - | $15.21 M(-5.0%) |
| Mar 2017 | - | $16.00 M(+9.8%) |
| Dec 2016 | $65.28 M(-16.1%) | $14.57 M(-20.0%) |
| Sep 2016 | - | $18.22 M(+10.5%) |
| Jun 2016 | - | $16.49 M(-5.9%) |
| Mar 2016 | - | $17.52 M(-18.7%) |
| Dec 2015 | $77.77 M(-3.8%) | $21.55 M(+32.8%) |
| Sep 2015 | - | $16.23 M(-22.6%) |
| Jun 2015 | - | $20.96 M(+10.1%) |
| Mar 2015 | - | $19.03 M |
| Dec 2014 | $80.87 M(+51.1%) | - |
| Dec 2013 | $53.52 M | - |
FAQ
- What is Aptevo Therapeutics annual total operating expenses?
- What is the all time high annual operating expenses for Aptevo Therapeutics?
- What is Aptevo Therapeutics annual operating expenses year-on-year change?
- What is Aptevo Therapeutics quarterly total operating expenses?
- What is the all time high quarterly operating expenses for Aptevo Therapeutics?
- What is Aptevo Therapeutics quarterly operating expenses year-on-year change?
What is Aptevo Therapeutics annual total operating expenses?
The current annual operating expenses of APVO is $24.60 M
What is the all time high annual operating expenses for Aptevo Therapeutics?
Aptevo Therapeutics all-time high annual total operating expenses is $80.87 M
What is Aptevo Therapeutics annual operating expenses year-on-year change?
Over the past year, APVO annual total operating expenses has changed by -$4.28 M (-14.81%)
What is Aptevo Therapeutics quarterly total operating expenses?
The current quarterly operating expenses of APVO is $6.38 M
What is the all time high quarterly operating expenses for Aptevo Therapeutics?
Aptevo Therapeutics all-time high quarterly total operating expenses is $21.55 M
What is Aptevo Therapeutics quarterly operating expenses year-on-year change?
Over the past year, APVO quarterly total operating expenses has changed by $0.00 (0.00%)